Nanomaterials: A powerful tool for tumor immunotherapy.

Front Immunol · 2022 · PMC9441741 · PMID 36072591

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This mesoporous material-based synergistic therapeutic system breaks the bottleneck of single-modality tumor treatment with low efficiency, high toxic side effects and easy drug resistance, which is highly significant for optimizing cancer treatment protocols.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.